Riboflavin (VB2) inhibits hepatocellular carcinogenesis by enhancing retinol metabolism and suppressing cell proliferation in Hras12V transgenic mice.

Front Oncol · 2026 · PMC13012928 · PMID 41889417

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not as significantno p-value reported

Additionally, VB2 exhibited inhibitory activity against the progression of established tumors, although this effect was not as significant as its suppression of hepatic tumorigenesis.

also in 271 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.